ASKA Pharmaceutical Holdings Co (TSE:4886) Other Operating Expense : 円24,219 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Other Operating Expense?

ASKA Pharmaceutical Holdings Co's Other Operating Expense for the three months ended in Dec. 2023 was 円5,974 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was 円24,219 Mil.

ASKA Pharmaceutical Holdings Co's quarterly Other Operating Expense increased from Jun. 2023 (円5,759 Mil) to Sep. 2023 (円6,371 Mil) but then declined from Sep. 2023 (円6,371 Mil) to Dec. 2023 (円5,974 Mil).

ASKA Pharmaceutical Holdings Co's annual Other Operating Expense increased from Mar. 2022 (円21,556 Mil) to Mar. 2023 (円23,476 Mil) but then declined from Mar. 2023 (円23,476 Mil) to Mar. 2024 (円55 Mil).

ASKA Pharmaceutical Holdings Co Other Operating Expense Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Other Operating Expense Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Other Operating Expense

21,556.00

23,476.00

55.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial							6,152.00	5,759.00	6,371.00	5,974.00	6,115.00

ASKA Pharmaceutical Holdings Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円24,219 Mil.

ASKA Pharmaceutical Holdings Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines